Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAFARELIN vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAFARELIN vs NALMEFENE: Safety Overview

Metric NAFARELIN NALMEFENE
Total FAERS Reports 209 197
Deaths Reported 9 77
Death Rate 4.3% 39.1%
Hospitalizations 99 118
Average Patient Age 34.7 yrs 44.2 yrs
% Female Patients 98.6% 39.3%
FDA Approval Date Feb 13, 1990 Apr 17, 1995
Manufacturer Pfizer Laboratories Div Pfizer Inc Purdue Pharma L.P.
Route NASAL INTRAMUSCULAR
Marketing Status Prescription Discontinued